These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3576021)

  • 21. DNA ploidy and TLI in association with other prognostic parameters in breast cancer.
    Midulla C; Cenci M; De Iorio P; Pisani T; Bonaccorsi A; De Marchis L; Nofroni I; Vecchione A
    Anticancer Res; 1999; 19(1A):381-4. PubMed ID: 10226571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in sensitivity to cyclophosphamide of mouse mammary tumors during serial transplantation.
    Sluyser M; De Goeij CC; Evers SG
    J Natl Cancer Inst; 1981 Feb; 66(2):327-30. PubMed ID: 6935481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some aspects of morphogenesis of Carcinoma mammae.
    Gabunia UA
    Folia Histochem Cytochem (Krakow); 1973; 11(3):169-76. PubMed ID: 4130446
    [No Abstract]   [Full Text] [Related]  

  • 24. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas.
    Engel LW; Young NA; Tralka TS; Lippman ME; O'Brien SJ; Joyce MJ
    Cancer Res; 1978 Oct; 38(10):3352-64. PubMed ID: 688225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of thymidine labelling index on fine needle aspirates from breast cancer: comparison with surgical samples.
    Barbieri F; Parodi G; Massa T; Cagnoli M; Barbi G; Imperiale A; Alama A
    Anticancer Res; 1994; 14(5A):1973-7. PubMed ID: 7847836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biochemical mechanisms of the stimulating action of estradiol on the growth of mammary tumours.
    Morozova TM; Mitina RL; Nagibneva IN; Ozhogina ZB; Salganik RI
    Exp Clin Endocrinol; 1986 Dec; 88(3):293-302. PubMed ID: 3030784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Estradiol reception and enzyme induction in mouse mammary gland neoplasms].
    Merkulova TI; Morozova TM; Iakovleva GE; Salganik RI
    Vopr Onkol; 1978; 24(8):19-26. PubMed ID: 695420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiestrogen modulation of the growth and properties of ovarian-autonomous and ovarian-dependent mammary tumors in rats.
    Tsai TL; Rutledge S; Katzenellenbogen BS
    Cancer Res; 1979 Dec; 39(12):5043-50. PubMed ID: 227594
    [No Abstract]   [Full Text] [Related]  

  • 29. Alternate fluctuations of leucine and thymidine incorporation by mammary tumors in rats during the estrous cycle.
    Lee C; Murphy JJ; Diamond CA; Rafferty NS; Oyasu R
    Cancer Res; 1977 Sep; 37(9):3301-5. PubMed ID: 406988
    [No Abstract]   [Full Text] [Related]  

  • 30. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of thyroid hormones on androgen responsiveness in a mammary tumor cell line.
    Sica G; Natoli C; Marchetti P; Iacobelli S
    J Steroid Biochem; 1981 Dec; 15():415-9. PubMed ID: 7339270
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipid metabolism and enzyme activities in hormone-dependent and hormone-independent mammary adenocarcinoma in GR mice.
    Abraham S; Briand P; Hansen FN
    J Natl Cancer Inst; 1986 Jul; 77(1):233-9. PubMed ID: 3088311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
    Erber S; Ringshandl R; von Angerer E
    Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone, serum, and methylxanthine interactions in the regulation of DNA synthesis in organ-cultured rat mammary tumors.
    Mayer RM; Diamond EJ; Hollander VP
    J Natl Cancer Inst; 1980 Nov; 65(5):1033-8. PubMed ID: 6159497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear protein phosphorylation and hormone-dependent mammary tumor regression following dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Cho-Chung YS; Redler BH; Lewallen RP
    Cancer Res; 1978 Oct; 38(10):3405-9. PubMed ID: 210937
    [No Abstract]   [Full Text] [Related]  

  • 36. alpha-Lactalbumin in human and subhuman primate normal mammary tissue and in human breast cancer as a marker for prolactin activity.
    Kleinberg DL; Todd J
    Cancer Res; 1978 Nov; 38(11 Pt 2):4318-22. PubMed ID: 100218
    [No Abstract]   [Full Text] [Related]  

  • 37. New species of hybridizable nuclear RNA in breast cancer cells.
    Turkington RW; Self DJ
    Cancer Res; 1970 Jun; 30(6):1833-40. PubMed ID: 5457944
    [No Abstract]   [Full Text] [Related]  

  • 38. Stimulation of mammary carcinoma cell proliferation by epithelial growth factor in vitro.
    Turkington RW
    Cancer Res; 1969 Jul; 29(7):1457-8. PubMed ID: 5799163
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of hypothyroidism on the induction and growth of mammary cancer induced by 7,12-dimethylbenz(a)anthracene in the rat.
    Goodman AD; Hoekstra SJ; Marsh PS
    Cancer Res; 1980 Jul; 40(7):2336-42. PubMed ID: 6770997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.